Advertisement

Related Videos

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Deborah Collyar: What's In It for Patients?

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Opening Session Panel Discussion

Advertisement

Advertisement




Jul
25
Today In Oncology
The Inflation Reduction Act and Ibrutinib
Update to ASCO Living Guideline for NSCLC Without Driver Alterations Includes First Comparison of Immunotherapy Options
Studies on EGFR Mutations and NRG1 Fusions Included in ASCO NSCLC Living Guideline Update
Patients With Interstitial Lung Disease Face Elevated Lung Cancer Risk, Study Finds
Intense Resistance Training for Breast Cancer Survivors With Lymphedema Risk
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo